ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers.
FDA Advisers Call for Cardiovascular-Safety Assessment of New Di...Courtesy MedPage Today Infectious Disease Thu, 07/03/2008 - 11:37
ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers. Sponsors
Related itemsJCI online early table of contents: Sept. 5, 2008
Rhode Island Hospital study finds link between obesity, type 2...
Are diabetes and obesity linked to periodontitis?
Class of diabetes drugs carries significant cardiovascular risks
Diabetes Drug Byetta: 6 Deaths Reported
|
Popular by tags Week |
Post new comment